MPLT Insider Trading Activity and SEC Form 4 Filings
MPLT insider trading summary
Over the past 12 months, insiders at MapLight Therapeutics, Inc. (MPLT) reported 145 sales worth $30.2M by 8 insiders and 5 open-market purchases worth $843K by 3 insiders on SEC Form 4. Net insider selling was $29.4M.
Latest MPLT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Christopher A. Kroeger | Chief Executive Officer | Sell | $595K (73,691 @ $8.08) |
| Oct 15, 2026 | Anatol Kreitzer | Chief Discovery Officer | Sell | $96K (12,248 @ $7.84) |
| Oct 15, 2026 | James Woodruff Lillie | Chief Scientific Officer | Sell | $93K (11,513 @ $8.08) |
| Oct 15, 2026 | Jonathan Gillis | CAO and Interim CFO | Sell | $82K (10,167 @ $8.08) |
| Oct 15, 2026 | Kristopher Hanson | General Counsel | Sell | $73K (9,020 @ $8.08) |
| Oct 15, 2026 | Erin Pennock Foff | Chief Medical Officer | Sell | $124K (15,355 @ $8.08) |
| Sep 16, 2026 | Kristopher Hanson | General Counsel | Sell | $193K (16,509 @ $11.67) |
| Aug 3, 2026 | James Woodruff Lillie | Chief Scientific Officer | Sell | $277K (22,082 @ $12.54) |
| Jul 28, 2026 | Troy Cox | Insider | Buy | $149K (15,620 @ $9.52) |
| Jul 17, 2026 | Erin Pennock Foff | Chief Medical Officer | Sell | $139K (3,656 @ $37.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.